These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4119645)

  • 1. The structure and isolation of pili (fimbriae) of Pseudomonas aeruginosa.
    Weiss RL; Raj HD
    Aust J Exp Biol Med Sci; 1972 Oct; 50(5):559-66. PubMed ID: 4119645
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antimicrobial agents on Pseudomonas aeruginosa strains isolated from sporadical cases and nosocomial infections.
    Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
    Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):227-38. PubMed ID: 3150919
    [No Abstract]   [Full Text] [Related]  

  • 3. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract]   [Full Text] [Related]  

  • 4. Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa strains isolated in Bogota, Columbia.
    Rodríguez B; Vásquez E; Sussmann O; Máttar S; Jaramillo CA
    Eur J Clin Microbiol Infect Dis; 2000 Feb; 19(2):152-4. PubMed ID: 10746508
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
    Arya SC; Agarwal N; Agarwal S
    Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
    [No Abstract]   [Full Text] [Related]  

  • 6. The structure and occurrence of pili (fimbriae) on Pseudomonas aeruginosa.
    Weiss RL
    J Gen Microbiol; 1971 Aug; 67(2):135-43. PubMed ID: 4108909
    [No Abstract]   [Full Text] [Related]  

  • 7. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009.
    Hawser SP
    Int J Antimicrob Agents; 2011 Jun; 37(6):587. PubMed ID: 21493045
    [No Abstract]   [Full Text] [Related]  

  • 9. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
    Chiaradia V; Santini GF
    G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
    [No Abstract]   [Full Text] [Related]  

  • 11. Phenotypic characterization of multidrug-resistant Pseudomonas aeruginosa strains isolated from pediatric patients associated to biofilm formation.
    Ochoa SA; Cruz-Córdova A; Rodea GE; Cázares-Domínguez V; Escalona G; Arellano-Galindo J; Hernández-Castro R; Reyes-López A; Xicohtencatl-Cortes J
    Microbiol Res; 2015 Mar; 172():68-78. PubMed ID: 25530579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian hospitals: CANWARD 2008-2011.
    Walkty A; Baxter M; Adam H; Karlowsky JA; Lagacé-Wiens P; Hoban DJ; Zhanel GG
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):361-4. PubMed ID: 22694789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of applying the new Clinical and Laboratory Standards Institute ticarcillin/clavulanic acid, piperacillin, piperacillin/tazobactam and imipenem susceptibility breakpoints for Pseudomonas aeruginosa in Hong Kong.
    Ho PL; Chow KH; Tse H; Cheng VC
    Int J Antimicrob Agents; 2012 Sep; 40(3):280-1. PubMed ID: 22795656
    [No Abstract]   [Full Text] [Related]  

  • 14. Ceftolozane-tazobactam resistance induced in vivo during the treatment of MDR Pseudomonas aeruginosa pneumonia.
    Plant AJ; Dunn A; Porter RJ
    Expert Rev Anti Infect Ther; 2018 May; 16(5):367-368. PubMed ID: 29727213
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on "Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa".
    Arya SC; Agarwal N; Agarwal S
    J Infect Chemother; 2008 Dec; 14(6):445-6. PubMed ID: 19089561
    [No Abstract]   [Full Text] [Related]  

  • 16. Serological and pyocin typing and antibiotic sensitivity of Pseudomonas aeruginosa strains.
    Del Piano M; La Palombara P; Picci A; Nicosia R
    Microbiologica; 1986 Apr; 9(2):253-8. PubMed ID: 3086671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First clonal spread of KPC-producing Pseudomonas aeruginosa in Buenos Aires, Argentina.
    Santella G; Cittadini R; Papalia M; Vera Ocampo C; Del Castillo M; Vay C; Gutkind G; Radice M
    Infect Genet Evol; 2012 Dec; 12(8):2003-5. PubMed ID: 22484108
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of ceftobiprole against clinical isolates of Pseudomonas aeruginosa obtained from Canadian intensive care unit (ICU) patients as part of the CAN-ICU Study.
    Walkty A; Decorby M; Nichol K; Karlowsky JA; Hoban DJ; Zhanel GG;
    J Antimicrob Chemother; 2008 Jul; 62(1):206-8. PubMed ID: 18385143
    [No Abstract]   [Full Text] [Related]  

  • 19. Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.
    Kunakonvichaya B; Thirapanmethee K; Khuntayaporn P; Montakantikul P; Chomnawang MT
    Int J Antimicrob Agents; 2015 May; 45(5):556-7. PubMed ID: 25724628
    [No Abstract]   [Full Text] [Related]  

  • 20. F116: a DNA bacteriophage specific for the pili of Pseudomonas aeruginosa strain PAO.
    Pemberton JM
    Virology; 1973 Oct; 55(2):558-60. PubMed ID: 4126411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.